Related Experiment Videos
Rehepatectomy for treating primary liver cancer
Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College = Chung-Kuo I Hsueh K'O Hsueh Yuan, Chung-Kuo Hsieh Ho I K'O Ta Hsueh Hsueh Pao
|January 1, 1989
Summary
Reoperation for liver cancer relapse, specifically rehepatectomy, shows encouraging survival rates. This study highlights the potential benefits of repeat liver resections for recurrent hepatocellular carcinoma.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Liver cancer relapse necessitates further treatment options.
- Reoperation for recurrent hepatocellular carcinoma is complex.
- Assessing outcomes of repeat hepatectomy is crucial.
Purpose of the Study:
- To evaluate the efficacy and outcomes of rehepatectomy in patients with relapsed liver cancer.
- To identify indicators for successful reintervention.
- To discuss surgical techniques and prophylactic measures for recurrent liver cancer.
Main Methods:
- Retrospective analysis of 41 patients undergoing reoperation for liver cancer relapse between 1960 and 1987.
- Detailed review of surgical procedures, including repeat hepatectomy (twice, thrice, or four times).
- Calculation and comparison of survival rates after initial and subsequent operations.
Main Results:
- Survival rates after the first hepatectomy were 100% (1-year), 69.58% (3-year), and 54.68% (5-year).
- Survival rates after the second hepatectomy were 75.0% (1-year), 34.62% (3-year), and 34.62% (5-year).
- Preliminary results indicate that rehepatectomy is a viable option with encouraging survival outcomes.
Conclusions:
- Rehepatectomy can achieve encouraging survival rates in selected patients with recurrent liver cancer.
- Further research is needed to refine indicators for reintervention and optimize prophylactic strategies.
- The study provides valuable insights into the long-term management of liver cancer relapse.